An Open Label, Multi-Center, Non-Interventional Post-Marketing Surveillance to Monitor the Safety and Efficacy of ALTARGO ® (Retapamulin) Administered in Korean Patients According to the Prescribing Information.

Conclusion: Topical retapamulin is to be well-tolerated and effective in patients with bacterial skin infections of locally approved prescribing information. PMID: 30065584 [PubMed]
Source: Annals of Dermatology - Category: Dermatology Tags: Ann Dermatol Source Type: research